
Chewy’s shares have tumbled from a Feb. 2021 high of $118.69 to about $33 as post‑pandemic demand cooled and rising rates compressed valuations; fiscal 2020 net sales surged 47% but growth slowed thereafter (net sales growth: FY2021 24%, FY2022 13%, FY2023 10%, FY2024 6%, 9M 2025 8%). The business has stabilized with Autoship representing 83.9% of Q3 2025 sales and adjusted EBITDA margin expanding from 0.9% (FY2021) to 4.8% (FY2024) and roughly 6% in 9M 2025; analysts forecast 2024–27 revenue and adjusted EBITDA CAGRs of 7% and 23%. At an enterprise value of $12.8bn (≈14x next year’s adjusted EBITDA), upside scenarios could be material if Chewy sustains customer and EBITDA growth, but competition from Amazon, inflationary pressures and a maturing core business make life‑changing returns unlikely.
Market structure: Amazon (AMZN) and omnichannel incumbents (WOOF/PETCO) are the primary beneficiaries if Chewy (CHWY) stalls — they can monetize scale, private-label deflation, and logistics to pressure prices. Chewy’s rising Autoship (83.9% of sales) and Chewy+ stickiness increase recurring revenue quality, supporting higher valuation multiple only if growth and adjusted EBITDA margins keep improving toward ~8–10%. Near-term investor focus will be on Autoship penetration, Chewy+ subscriber metrics, and quarterly EBITDA margins as re-rating catalysts. Risk assessment: Tail risks include an aggressive Amazon private-label push capturing >5–10% share of Chewy SKUs within 12–18 months, a recession-driven drop in discretionary pet spend (net sales decline >5% YoY), or rising logistics costs compressing EBITDA by >300bps. Immediate (days) risk is earnings-driven volatility; short-term (3–6 months) is holiday sales and promotions; long-term (3–5 years) hinges on cross-selling ancillary services and margin expansion. Hidden dependency: margin improvement depends on lower fulfillment cost per order and stable Autoship churn, not just top-line recovery. Trade implications: Tactical small longs in CHWY are defensible but size-constrained; CHWY trades at ~14x FY+1 EBITDA (EV $12.8bn) — a base-case 2x price recovery is realistic if EBITDA CAGR ≈15% to 2035 and multiple expands to ~20x. Implement asymmetric option structures (long-dated call spreads for upside capture, short-dated put spreads for downside hedging) and consider pair trades exploiting Amazon’s scale (long AMZN / short CHWY) over 6–12 months. Contrarian angles: The market may underappreciate Autoship revenue durability — if Autoship >85% and churn falls <5% annualized, CHWY could re-rate sooner than consensus. Conversely, the market may be underestimating capital intensity of vet clinics and insurance pushes; if these initiatives fail to scale EBITDA, downside to $20–25 is plausible. Re-rate triggers to watch: adjusted EBITDA margin >8% by FY2026, Chewy+ disclosed subs growth, or Amazon private-label share rising >5% of pet category within 12 months.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.35
Ticker Sentiment